A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells. (2019)

First Author: Orienti I
Attributed to:  The role of p53/p73 family members in the cytotoxic response funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13046-019-1383-9

PubMed Identifier: 31439019

Publication URI: http://europepmc.org/abstract/MED/31439019

Type: Journal Article/Review

Volume: 38

Parent Publication: Journal of experimental & clinical cancer research : CR

Issue: 1

ISSN: 0392-9078